Puskas John D, Kilgo Patrick D, Kutner Michael, Pusca Sorin V, Lattouf Omar, Guyton Robert A
Emory Heart Center, Division of Cardiothoracic Surgery, Clinical Research Unit, Emory University School of Medicine, Atlanta, GA, USA.
Circulation. 2007 Sep 11;116(11 Suppl):I192-9. doi: 10.1161/CIRCULATIONAHA.106.678979.
Women experience greater morbidity and mortality than men after conventional coronary artery bypass grafting (CABG) on cardiopulmonary bypass (CPB). The objective of this study was to determine whether off-pump CABG (OPCAB) alters this gender-based disparity.
Retrospective review of risk factors and clinical outcomes for 11 413 consecutive patients having isolated CABG between January 1, 1997, and May 31, 2005, at a US academic center. Interventions were OPCAB or CABG/CPB, performed at the discretion of 14 faculty surgeons. Main outcome measures included in-hospital death, stroke, myocardial infarction or combined major adverse cardiac events (MACE = death or stroke or myocardial infarction). Odds ratios of adverse events, adjusted for 31 risk factors, were compared between women and men who had OPCAB versus CABG/CPB. Covariates included Propensity Score, Society of Thoracic Surgeons' Predicted Risk, surgeon and body habitus. Female patients (n=3248) and those treated with OPCAB (n=4492) were older, had more comorbidities and higher predicted risk than male patients (n=8165) and those treated with conventional CABG/CPB (n=6921), respectively. Women treated with CABG/CPB had a risk-adjusted odds ratio of 1.60 for death (P=0.01), 1.71 for stroke (P=0.007), 2.26 for myocardial infarction (P=0.008) and 1.71 for MACE (P<0.001) compared with men who had CABG/CPB. In contrast, women treated with OPCAB had outcomes statistically similar to men who had either OPCAB or CABG/CPB. Among women, OPCAB was associated with a significant reduction in death (OR 0.39, P=0.001), stroke (OR 0.43, P=0.002) and MACE (OR 0.43, P<0.001).
OPCAB is associated with fewer major adverse cardiac events and benefits women disproportionately, thereby narrowing the gender disparity in clinical outcomes after CABG.
在接受传统体外循环冠状动脉搭桥术(CABG)后,女性的发病率和死亡率高于男性。本研究的目的是确定非体外循环冠状动脉搭桥术(OPCAB)是否会改变这种基于性别的差异。
对1997年1月1日至2005年5月31日期间在美国一家学术中心连续进行单纯CABG的11413例患者的危险因素和临床结果进行回顾性分析。干预措施为OPCAB或CABG/CPB,由14名外科医生酌情实施。主要结局指标包括住院死亡、中风、心肌梗死或合并的主要不良心脏事件(MACE = 死亡或中风或心肌梗死)。比较接受OPCAB与CABG/CPB的女性和男性在调整31个危险因素后的不良事件比值比。协变量包括倾向评分、胸外科医师协会预测风险、外科医生和身体形态。女性患者(n = 3248)和接受OPCAB治疗的患者(n = 4492)分别比男性患者(n = 8165)和接受传统CABG/CPB治疗的患者(n = 6921)年龄更大、合并症更多且预测风险更高。与接受CABG/CPB的男性相比,接受CABG/CPB的女性死亡的风险调整比值比为1.60(P = 0.01),中风为1.71(P = 0.007),心肌梗死为2.26(P = 0.008),MACE为1.71(P < 0.001)。相比之下,接受OPCAB治疗的女性的结局在统计学上与接受OPCAB或CABG/CPB的男性相似。在女性中,OPCAB与死亡(OR 0.39,P = 0.001)、中风(OR 0.43,P = 0.002)和MACE(OR 0.43,P < 0.001)的显著降低相关。
OPCAB与较少的主要不良心脏事件相关,且对女性的益处尤为显著,从而缩小了CABG术后临床结局的性别差异。